Trinity Biotech plc (TRIB) — Cash Flow-to-Debt Ratio
Trinity Biotech plc (TRIB) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of $-71.45K could theoretically repay 0% of its total liabilities ($158.43 Million) in one year. Explore TRIB strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Trinity Biotech plc Cash Flow-to-Debt Ratio (1993–2024)
Historical debt coverage capacity for Trinity Biotech plc across 32 annual periods. Also explore Trinity Biotech plc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Trinity Biotech plc (1993–2024)
Year-by-year debt coverage analysis for Trinity Biotech plc. For market capitalisation and broader financial context, see Trinity Biotech plc (TRIB) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | $-4.19 Million | $138.47 Million | ▲ +78.2% |
| 2023 | -0.14x | $-11.56 Million | $83.38 Million | ▼ -1318.8% |
| 2022 | -0.01x | $-921.00K | $94.28 Million | ▼ -108.8% |
| 2021 | 0.11x | $13.24 Million | $119.21 Million | ▼ -38.0% |
| 2020 | 0.18x | $23.75 Million | $132.62 Million | ▲ +313.5% |
| 2019 | 0.04x | $5.47 Million | $126.36 Million | ▼ -33.0% |
| 2018 | 0.06x | $6.93 Million | $107.18 Million | ▼ -31.9% |
| 2017 | 0.10x | $12.11 Million | $127.42 Million | ▼ -2.8% |
| 2016 | 0.10x | $13.77 Million | $140.87 Million | ▲ +15.0% |
| 2015 | 0.09x | $12.34 Million | $145.07 Million | ▼ -75.2% |
| 2014 | 0.34x | $15.75 Million | $45.87 Million | ▲ +27.6% |
| 2013 | 0.27x | $11.71 Million | $43.48 Million | ▼ -62.4% |
| 2012 | 0.72x | $20.06 Million | $28.03 Million | ▼ -29.5% |
| 2011 | 1.02x | $20.48 Million | $20.17 Million | ▼ -13.8% |
| 2010 | 1.18x | $23.07 Million | $19.59 Million | ▲ +324.6% |
| 2009 | 0.28x | $14.73 Million | $53.10 Million | ▲ +64.5% |
| 2008 | 0.17x | $10.73 Million | $63.60 Million | ▼ -13.0% |
| 2007 | 0.19x | $15.35 Million | $79.13 Million | ▲ +115.5% |
| 2006 | 0.09x | $7.37 Million | $81.87 Million | ▼ -50.2% |
| 2005 | 0.18x | $9.21 Million | $50.98 Million | ▲ +14818.8% |
| 2004 | 0.00x | $42.00K | $34.69 Million | ▼ -98.7% |
| 2003 | 0.10x | $3.60 Million | $37.83 Million | ▼ -78.4% |
| 2002 | 0.44x | $11.65 Million | $26.36 Million | ▲ +79.0% |
| 2001 | 0.25x | $5.06 Million | $20.50 Million | ▼ -0.4% |
| 2000 | 0.25x | $3.02 Million | $12.19 Million | ▲ +44.8% |
| 1999 | 0.17x | $3.82 Million | $22.32 Million | ▲ +620.5% |
| 1998 | -0.03x | $-1.00 Million | $30.40 Million | ▲ +58.9% |
| 1997 | -0.08x | $-1.40 Million | $17.50 Million | ▲ +93.8% |
| 1996 | -1.29x | $-3.60 Million | $2.80 Million | ▼ -173.2% |
| 1995 | -0.47x | $-800.00K | $1.70 Million | ▲ +72.7% |
| 1994 | -1.72x | $-3.10 Million | $1.80 Million | ▼ -29.2% |
| 1993 | -1.33x | $-2.40 Million | $1.80 Million | — |